| Phase 4 |
| NCT05776056 |
Methylphenidate for the Treatment of PTSD With Associated Neurocognitive Complaints |
VA Office of Research and Development |
Recruiting |
2026-08-19 |
| NCT06573970 |
Atomoxetine and Executive Function in PTSD |
VA Office of Research and Development |
Recruiting |
2026-07-07 |
| NCT06852469 |
Computational Assessment of GABA Receptor Modulation in PTSD |
VA Office of Research and Development |
Recruiting |
2026-06-16 |
| NCT07382596 |
Cervical Plexus Hydrodissection With D5W Versus NS for Treatment-Resistant PTSD |
Dr. Dean Reeves Clinic |
Recruiting |
2026-05-19 |
| NCT05853627 |
Mismatch vs. Standard Intervention During Memory Reconsolidation Blockade With… |
Massachusetts General Hospital |
Recruiting |
2026-05-06 |
| NCT06903819 |
Ketamine for Pain, Opioid Use, and Mental Health in Orthopedic Trauma Patients |
Texas Tech University Health Sciences Center |
Recruiting |
2026-03-24 |
| NCT03642028 |
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in… |
VA Office of Research and Development |
Recruiting |
2025-07-18 |
| NCT06414356 |
The Effect of Outpatient Ketamine Infusion on Chronic Neuropathic Pain and PTSD |
Margaux M. Salas, PhD |
Recruiting |
2025-02-25 |
| NCT07686731 |
Suvorexant 3 - PE-PC |
Northern California Institute of Research and Education |
Not Yet Recruiting |
2026-07-07 |
| NCT04961190 |
A Comparison of Prolonged Exposure Therapy, Pharmacotherapy, and Their Combination for… |
University of Pennsylvania |
Active, Not Recruiting |
2026-06-09 |
| NCT06788522 |
The Effects of Orexin Antagonism on Fear Extinction in PTSD |
VA Office of Research and Development |
Not Yet Recruiting |
2026-06-02 |
| NCT05391971 |
Effects of Stellate Ganglion Block in Post-traumatic Stress Disorder |
NYU Langone Health |
Active, Not Recruiting |
2026-04-09 |
| NCT07192536 |
Accelerated Neuromodulation for Concurrent Post-Traumatic Stress Disorder (PTSD) &… |
Legion Veterans Village Research Foundation |
Not Yet Recruiting |
2025-11-18 |
| Phase 3 |
| NCT07703722 |
Effect of Psilocybin and Structured Integrated Reframing Therapy on Gut-Brain Axis… |
Khyber Medical University Peshawar |
Recruiting |
2026-07-14 |
| NCT07456696 |
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1) |
Transcend Therapeutics |
Recruiting |
2026-06-12 |
| NCT07280065 |
REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool |
Senseye, Inc. |
Recruiting |
2026-04-29 |
| NCT04877093 |
Repurposing Low-Dose Clonidine for PTSD in Veterans |
Wake Forest University Health Sciences |
Recruiting |
2026-03-31 |
| NCT06412757 |
Silexan in the Treatment Of Posttraumatic Stress Disorder Trial |
Deakin University |
Recruiting |
2025-12-18 |
| NCT06394284 |
Examining 3,4-methylenedioxymethamphetamine (MDMA) Effects on Psychological, Relational… |
Herzog Hospital |
Recruiting |
2024-05-01 |
| NCT04985344 |
Treatment of Pediatric Post-traumatic Stress Disorder With Memory Reactivation Under the… |
University Hospital, Toulouse |
Recruiting |
2023-08-28 |
| NCT04801589 |
Goal-Directed Sedation in Mechanically Ventilated Infants and Children |
Vanderbilt University Medical Center |
Active, Not Recruiting |
2026-09-11 |
| NCT07670702 |
An Evaluation of the Long-Term Safety and Efficacy of TSND-201 for the Treatment of PTSD |
Transcend Therapeutics |
Enrolling by Invitation |
2026-09-04 |
| NCT07792122 |
Women Who Are Victims of Violence: Treatment of PTSD Through Reactivation of Traumatic… |
University Hospital, Toulouse |
Not Yet Recruiting |
2026-08-28 |
| NCT06117306 |
MDMA-assisted Massed Prolonged Exposure for PTSD |
Healing Breakthrough |
Active, Not Recruiting |
2026-08-26 |
| NCT03539614 |
Predicting Responses to PTSD Treatment With Iris and Cardiovascular Tests |
VA Office of Research and Development |
Active, Not Recruiting |
2026-08-14 |